The Biden administration said it did not know of manufacturing problems at the Emergent factory when it approved shipping millions of doses of AstraZeneca’s vaccine. The company says the doses were safe.
Top Investments for 2025: A Focus on the S&P 500
As we move into 2025, the S&P 500 continues to be a cornerstone of investment strategies, offering insights into the U.S. stock market’s health. Following